Cytotoxicity of antiviral nucleotides adefovir and cidofovir is induced by the expression of human renal organic anion transporter 1

Journal of the American Society of Nephrology

Volumn 11, Issue 3, 2000, Pages 383-393

  Ho, Edmund S ^a   Lin, Deborah C ^a   Mendel, Dirk B ^a   Cihlar, Tomas ^a  

^a GILEAD SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADEFOVIR; ANTIPORTER; CIDOFOVIR;

ANIMAL CELL; ANION TRANSPORT; ARTICLE; CHO CELL; CONTROLLED STUDY; DRUG CYTOTOXICITY; HUMAN; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0034008388     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Pritchard JB, Miller DS: Renal secretion of organic anions and cations. Kidney Int 49: 1649-1654, 1996
2. Roch-Ramel F: Renal transport of organic anions. Curr Opin Nephrol Hypertens 1: 517-524, 1998
3. Sekine T, Watanabe N, Hosoyamada M, Kainai Y, Endou H: Expression cloning and characterization of a novel multispecific organic anion transporter. J Biol Chem 272: 18526-18529, 1997
4. Sweet D, Wolff N, Pritchard J: Expression cloning and characterization of ROAT1. J Biol Chem 272: 30088-30095, 1997
5. Kuze K, Graves P, Leahy A, Wilson P, Stuhlmann H, You G: Heterologous expression and functional characterization of a mouse renal organic anion transporter in mammalian cells. J Biol Chem 274: 1519-1524, 1999
6. Wolff NA, Werner A, Burkhardt S, Burkhardt G: Expression cloning and characterization of a renal organic anion transporter from winter flounder. FEBS Lett 417: 287-291, 1997
7. Apiwattanakul N, Sekine T, Chairoungdua A, Kanai Y, Nakajima N, Sophasan S, Endou H: Transport properties of nonsteroidal anti-inflammatory drugs by organic anion transporter 1 expressed in Xenopus laevis oocytes. Mol Pharmacol 55: 847-854, 1999
8. Tojo A, Sekine T, Nakajima N, Hosoyamada M, Kanai Y, Kimura K, Endou H: Immunohistochemical localization of multispecific renal organic anion transporter 1 in rat kidney. J Am Soc Nephrol 10: 464-471, 1999
9. Cihlar T, Lin DC, Pritchard JB, Fuller MD, Mendel DB, Sweet DH: The antiviral nucleotide analogs cidofovir and adefovir are novel substrates for human and rat renal organic anion transporter 1. Mol Pharmacol 56: 570-580, 1999
10. Hosoyamada M, Sekine T, Kanai Y, Endou H: Molecular cloning and functional expression of a multispecific organic anion transporter from human kidney. Am J Physiol 276: F122-F128, 1999
11. Lu R, Chan BS, Schuster VL: Cloning of the human kidney PAH transporter: Narrow substrate specificity and regulation by protein kinase C. Am J Physiol 276: F295-F303, 1999
12. Hitchcock MJM, Jaffe HS, Martin JC, Stagg RJ: Cidofovir, a new agent with potent anti-herpesvirus activity. Antiviral Chem Chemother 7: 115-127, 1996
13. Cihlar T, Bischofberger N: PMEA and PMPA: Acyclic nucleoside phosphonates with potent anti-HIV activity. In: Trends in Drug Research II, Vol. 29, edited by Van der Goot H, Amsterdam, Elsevier, 1998, pp 105-116
14. Cundy KC, Petty BG, Flaherty J, Fisher PE, Polis MA, Wachsman M, Lietman PS, Lalezari JP, Hitchcock MJM, Jaffe HS: Clinical pharmacokinetics of cidofovir in human immunodeficiency virus-infected patients. Antimicrob Agents Chemother 39: 1247-1252, 1995
15. Cundy KC, Barditch-Crovo P, Walker RE, Collier AC, Ebeling D, Toole J, Jaffe HS: Clinical pharmacokinetics of adefovir in human immunodeficiency virus type 1-infected patients. Antimicrob Agents Chemother 39: 2401-2405, 1995
16. Lalezari JP, Stagg RJ, Kuppermann BD, Holland GN, Kramer F, Ives DV, Youle M, Robinson MR, Drew WL, Jaffe HS: Intravenous cidofovir for peripheral cytomegalovirus retinitis in patients with AIDS: A randomized, controlled trial. Ann Intern Med 126: 257-263, 1997
17. Fisher E, Brosgart C, Cohn D, Chaloner K, Pulling C, Scmetter B, Alston B, El-Sadr W, CPCRA 039 Team: Safety of adefovir dipivoxil (ADV) and incidence of proximal renal tubular disorders (PRTD) in a placebo-controlled trial in patients with advanced HIV disease [Abstract 678]. Presented at the 6th Conference on Retroviruses and Opportunistic Injections, Chicago, IL, 1999
18. Tune BM: Nephrotoxicity of beta-lactam antibiotics: Mechanisms and strategies for prevention. Pediatr Nephrol 11: 768-772, 1997
19. Cihlar T, Fuller MD, Cherrington JM: Expression of the catalytic subunit (UL54) and the accessory protein (UL44) of human cytomegalovirus DNA polymerase in a coupled in vitro transcription/translation system. Protein Expr Purif 11: 209-218, 1997
20. Kozak M: An analysis of 5′-noncoding sequences from 699 vertebrate messenger RNAs. Nucleic Acids Res 15: 8125-8148, 1987
21. Cihlar T, Rosenberg I, Votruba I, Holy A: Transport of 9-(2-phosphonylmethoxyethyl)adenine across plasma membrane of HeLa S3 cells is protein mediated. Antimicrob Agents Chemother 39: 117-124, 1995
22. Cihlar T, Votruba I, Horska K, Liboska R, Rosenberg I, Holy A: Metabolism of 1-(S)-(3-hydroxy-2-phosphonomethoxypropyl-)cytosine (HPMPC) in human embryonic lung cells. Collect Czech Chem Commun 57: 661-672, 1992
23. Carmichael J, DeGraff WG, Gazdar AF, Minna JD, Mitchell JB: Evaluation of a tetrazolium-based semiautomated colorimetric assay: Assessment of chemosensitivity testing. Cancer Res 47: 936-942, 1987
24. Holy A, Rosenberg I: Synthesis of 9-(2-phosphonylmethoxyethyl)adenine and related compounds. Collect Czech Chem Commun 52: 2801-2809, 1987
25. Balzarini J, Hao Z, Herdewijn P, Johns DG, De Clercq E: Intracellular metabolism and mechanism of anti-retrovirus action of 9-(2-phosphonylmethoxyethyl)adenine, a potent anti-human immunodeficiency virus compound. Proc Natl Acad Sci USA 88: 1499-1503, 1991
26. Ho HT, Woods KL, Bronson JJ, De Boeck H, Martin JC, Hitchcock MJM: Intracellular metabolism of the antiherpes agent (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine. Mol Pharmacol 41: 197-202, 1992
27. Palu G, Stefanelli S, Rassu M, Parolin C, Balzarini J, De Clercq E: Cellular uptake of phosphonylmethoxyalkylpurine derivatives. Antiviral Res 16: 115-119, 1991
28. Olsanska L, Cihlar T, Votruba I, Holy A: Transport of adefovir (PMEA) in human T-lymphoblastoid cells. Collect Czech Chem Commun 62: 821-828, 1997
29. Connelly MC, Robbins BL, Fridland A: Mechanism of uptake of the phosphonate analog (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC) in Vero cells. Biochem Pharmacol 46: 1053-1057, 1993
30. Feller N, Broxterman HJ, Wahrer DC, Pinedo HM: ATP-dependent efflux of calcein by the multidrug resistance protein (MRP): No inhibition by intracellular glutathione depletion. FEBS Lett 368: 385-388, 1995
31. Courtois A, Payen L, Lagadic D, Guillouzo A, Fardel O: Evidence for a multidrug resistance-associated protein 1 (MRP1)-related transport system in cultured rat liver biliary epithelial cells. Life Sci 64: 763-774, 1999
32. a Prediction for Organic Acids and Bases, London, Chapman and Hall, 1981
33. Ullrich KJ, Rumrich G, Kloss S: Contraluminal para-aminohippurate transport in the proximal tubule of the rat kidney. IV. Specificity: Mono- and polysubstituted benzene analogs. Pflügers Arch 413: 134-146, 1988
34. Kekuda R, Prasad PD, Wu X, Wang H, Fei YJ: Cloning and functional characterization of a potential-sensitive, polyspecific organic cation transporter (OCT3) most abundantly expressed in placenta. J Biol Chem 273: 15971-15979, 1998
35. Kucera GL, Capizzi RL: 1-Beta-D-arabinofuranosylcytosine-diphosphate-choline is formed by the reversal of cholinephosphotransferase and not via cytidylyltransferase. Cancer Res 52: 3886-3891, 1992
36. Puglielli L, Mandon EC, Hirschberg CB: Identification, purification, and characterization of the rat liver Golgi membrane ATP transporter. J Biol Chem 274: 12665-12669, 1999
37. Klingenberg M: Structure-function of the ADP/ATP carrier. Biochem Soc Trans 20: 547-550, 1992
38. Schaub T, Kartenbeck J, Konig J, Spring H, Dorsam J, Staehler G, Storkel S, Thon WF, Keppler D: Expression of the MRP-2 gene-encoded conjugate export pump in human kidney proximal tubules and in renal cell carcinoma. J Am Soc Nephrol 10: 1159-1169, 1999
39. Cundy KC, Li ZH, Lee WA: Effect of probenecid on the distribution, metabolism, and excretion of cidofovir in rabbits. Drug Metab Dispos 24: 315-321, 1996
40. Holloway LS, Cassin S: In vitro uptake of PAH by choroid plexus from dogs of various ages. Am J Physiol 223: 507-509, 1972
41. Miller TB, Ross CR: Transport of organic cations and anions by choroid plexus. J Pharmacol Exp Ther 196: 771-777, 1972
42. Hakvoort A, Haselbach M, Galla HJ: Active transport properties of porcine choroid plexus cells in culture. Brain Res 795: 247-256, 1998
43. Ogawa M, Suzuki H, Sawada Y, Hanano M, Sugiyama Y: Kinetics of active efflux via choroid plexus of beta-lactam antibiotics from the CSF into the circulation. Am J Physiol 266: R392-R399, 1994
44. Hitchcock MJM, Lacy SA, Lindsey JR, Kern ER: The cyclic congener of cidofovir has reduced nephrotoxicity in three species [Abstract]. Antiviral Res 26: A358, 1995
45. Cundy KC, Bidgood AM, Lynch G, Shaw JP, Griffin L, Lee WA: Pharmacokinetics, bioavailability, metabolism, and tissue distribution of cidofovir (HPMPC) and cyclic HPMPC in rats. Drug Metab Dispos 24: 745-752, 1996
46. Jacobs C, Kaubisch S, Halsey J, Lum BL, Gosland M, Coleman CM, Sikic BI: The use of probenecid as a chemoprotector against cisplatin nephrotoxicity. Cancer 67: 1518-1524, 1991
47. Hirouchi Y, Naganuma H, Kawahara Y, Okada R, Kamiya A, Inui K, Hori R: Preventive effect of betamipron on nephrotoxicity and uptake of carbapenems in rabbit renal cortex. Jpn J Pharmacol 66: 1-6, 1994
48. Kim SH, Kim WB, Kwon JW, Lee MG: Nephroprotective effect of betamipron on a new carbapenem, DA-1131, in rabbits. Biopharm Drug Dispos 20: 125-129, 1999
49. Lacy SA, Hitchcock MJM, Lee WA, Tellier P, Cundy KC: Effect of oral probenecid coadministration on the chronic toxicity and pharmacokinetics of intravenous cidofovir in cynomolgus monkeys. Toxicol Sci 4: 97-106, 1998